HMG CoA reductase inhibitors and PPAR-α activators: Are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials? Jean-Charles FruchartPatrick Duriez Invited Commentary Pages: 403 - 404
Update on the role of triglycerides as a risk factor for coronary heart disease Michael MillerBarbara CosgroveStephen Havas OriginalPaper Pages: 414 - 418
Dietary fats and coronary heart disease pathogenesis Serge RenaudDominique Lanzmann-Petithory OriginalPaper Pages: 419 - 424
Dietary cholesterol and coronary heart disease William E. ConnorSonja L. Connor OriginalPaper Pages: 425 - 432
Therapeutic lifestyle change and adult treatment panel III: Evidence then and now Neil J. StoneLinda Van Horn OriginalPaper Pages: 433 - 443
Dietary glycemic load and atherothrombotic risk Simin LiuWalter C. Willett OriginalPaper Pages: 454 - 461
Dietary patterns and risk of hypertension, type 2 diabetes mellitus, and coronary heart disease Matthias B. SchulzeFrank B. Hu OriginalPaper Pages: 462 - 467
Cardiorespiratory fitness and physical activity as risk predictors of future atherosclerotic cardiovascular diseases Jari A. LaukkanenSudhir KurlJukka T. Salonen OriginalPaper Pages: 468 - 476
